APO Research
Talk to an analyst

APO RESEARCH · REPORT

Child-resistant Pharmaceutical Packaging

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Child-resistant Pharmaceutical Packaging Market Outlook and Growth Opportunities 2026

28 December 2025204 pages

Choose your research edition.

Industry ResearchChild-resistant Pharmaceutical Packaging Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Child-resistant Pharmaceutical Packaging Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Child-resistant Pharmaceutical Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Child-resistant Pharmaceutical Packaging Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Child-resistant Pharmaceutical Packaging Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Child-resistant Pharmaceutical Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Child-resistant Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Child-resistant Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Child-resistant Pharmaceutical Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Child-resistant Pharmaceutical Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Child-resistant Pharmaceutical Packaging market include Amcor, Sanner GmbH, Origin Pharma Packaging, WestRock, Colbert Packaging, Kaufman Container, LeafLocker, Mold-Rite Plastics and Körber Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Child-resistant Pharmaceutical Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Child-resistant Pharmaceutical Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Child-resistant Pharmaceutical Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Child-resistant Pharmaceutical Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.

Child-resistant Pharmaceutical Packaging Segment by Company

Amcor

Sanner GmbH

Origin Pharma Packaging

WestRock

Colbert Packaging

Kaufman Container

LeafLocker

Mold-Rite Plastics

Körber Pharma

Gerresheimer

Drug Plastics

Locked4Kids

Aluberg

IGBressan

BOBST

SGD Pharma

Dymapak

Child-resistant Pharmaceutical Packaging Segment by Type

Peel Off Type

Press Type

Others

Child-resistant Pharmaceutical Packaging Segment by Application

Household

Commercial

Child-resistant Pharmaceutical Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Child-resistant Pharmaceutical Packaging status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Child-resistant Pharmaceutical Packaging market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Child-resistant Pharmaceutical Packaging significant trends, drivers, influence factors in global and regions.

6. To analyze Child-resistant Pharmaceutical Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Child-resistant Pharmaceutical Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Child-resistant Pharmaceutical Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Child-resistant Pharmaceutical Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Child-resistant Pharmaceutical Packaging market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Child-resistant Pharmaceutical Packaging industry.

Chapter 3: Detailed analysis of Child-resistant Pharmaceutical Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Child-resistant Pharmaceutical Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Child-resistant Pharmaceutical Packaging in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Child-resistant Pharmaceutical Packaging Industry Trends Table 2. Child-resistant Pharmaceutical Packaging Industry Drivers Table 3. Child-resistant Pharmaceutical Packaging Industry Opportunities and Challenges Table 4. Child-resistant Pharmaceutical Packaging Industry Restraints Table 5. Global Child-resistant Pharmaceutical Packaging Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Child-resistant Pharmaceutical Packaging Revenue Share by Company (2021-2026) Table 7. Global Child-resistant Pharmaceutical Packaging Sales Volume by Company (k units) & (2021-2026) Table 8. Global Child-resistant Pharmaceutical Packaging Sales Volume Share by Company (2021-2026) Table 9. Global Child-resistant Pharmaceutical Packaging Average Price (USD/unit) of Company (2021-2026) Table 10. Global Child-resistant Pharmaceutical Packaging Company Ranking, (2024-2026) & (USD Million) Table 11. Global Child-resistant Pharmaceutical Packaging Key Company Manufacturing Base & Headquarters Table 12. Global Child-resistant Pharmaceutical Packaging Company, Product Type & Application Table 13. Global Child-resistant Pharmaceutical Packaging Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Child-resistant Pharmaceutical Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Peel Off Type Table 18. Significant Companies of Press Type Table 19. Significant Companies of Others Table 20. Global Child-resistant Pharmaceutical Packaging Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Child-resistant Pharmaceutical Packaging Sales Volume by Type (2021-2026) & (k units) Table 22. Global Child-resistant Pharmaceutical Packaging Sales Volume by Type (2027-2032) & (k units) Table 23. Global Child-resistant Pharmaceutical Packaging Sales Volume Share by Type (2021-2026) Table 24. Global Child-resistant Pharmaceutical Packaging Sales Volume Share by Type (2027-2032) Table 25. Global Child-resistant Pharmaceutical Packaging Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Child-resistant Pharmaceutical Packaging Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Child-resistant Pharmaceutical Packaging Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Child-resistant Pharmaceutical Packaging Sales Value Share by Type (2021-2026) Table 29. Global Child-resistant Pharmaceutical Packaging Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Household Table 31. Significant Companies of Commercial Table 32. Global Child-resistant Pharmaceutical Packaging Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Child-resistant Pharmaceutical Packaging Sales Volume by Application (2021-2026) & (k units) Table 34. Global Child-resistant Pharmaceutical Packaging Sales Volume by Application (2027-2032) & (k units) Table 35. Global Child-resistant Pharmaceutical Packaging Sales Volume Share by Application (2021-2026) Table 36. Global Child-resistant Pharmaceutical Packaging Sales Volume Share by Application (2027-2032) Table 37. Global Child-resistant Pharmaceutical Packaging Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Child-resistant Pharmaceutical Packaging Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Child-resistant Pharmaceutical Packaging Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Child-resistant Pharmaceutical Packaging Sales Value Share by Application (2021-2026) Table 41. Global Child-resistant Pharmaceutical Packaging Sales Value Share by Application (2027-2032) Table 42. Global Child-resistant Pharmaceutical Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Child-resistant Pharmaceutical Packaging Sales by Region (2021-2026) & (k units) Table 44. Global Child-resistant Pharmaceutical Packaging Sales Market Share by Region (2021-2026) Table 45. Global Child-resistant Pharmaceutical Packaging Sales by Region (2027-2032) & (k units) Table 46. Global Child-resistant Pharmaceutical Packaging Sales Market Share by Region (2027-2032) Table 47. Global Child-resistant Pharmaceutical Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Child-resistant Pharmaceutical Packaging Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Child-resistant Pharmaceutical Packaging Sales Value Share by Region (2021-2026) Table 50. Global Child-resistant Pharmaceutical Packaging Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Child-resistant Pharmaceutical Packaging Sales Value Share by Region (2027-2032) Table 52. Global Child-resistant Pharmaceutical Packaging Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Child-resistant Pharmaceutical Packaging Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Child-resistant Pharmaceutical Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Child-resistant Pharmaceutical Packaging Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Child-resistant Pharmaceutical Packaging Sales by Country (2021-2026) & (k units) Table 57. Global Child-resistant Pharmaceutical Packaging Sales Market Share by Country (2021-2026) Table 58. Global Child-resistant Pharmaceutical Packaging Sales by Country (2027-2032) & (k units) Table 59. Global Child-resistant Pharmaceutical Packaging Sales Market Share by Country (2027-2032) Table 60. Global Child-resistant Pharmaceutical Packaging Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Child-resistant Pharmaceutical Packaging Sales Value Market Share by Country (2021-2026) Table 62. Global Child-resistant Pharmaceutical Packaging Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Child-resistant Pharmaceutical Packaging Sales Value Market Share by Country (2027-2032) Table 64. Amcor Company Information Table 65. Amcor Business Overview Table 66. Amcor Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Amcor Child-resistant Pharmaceutical Packaging Product Portfolio Table 68. Amcor Recent Development Table 69. Sanner GmbH Company Information Table 70. Sanner GmbH Business Overview Table 71. Sanner GmbH Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Sanner GmbH Child-resistant Pharmaceutical Packaging Product Portfolio Table 73. Sanner GmbH Recent Development Table 74. Origin Pharma Packaging Company Information Table 75. Origin Pharma Packaging Business Overview Table 76. Origin Pharma Packaging Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Origin Pharma Packaging Child-resistant Pharmaceutical Packaging Product Portfolio Table 78. Origin Pharma Packaging Recent Development Table 79. WestRock Company Information Table 80. WestRock Business Overview Table 81. WestRock Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. WestRock Child-resistant Pharmaceutical Packaging Product Portfolio Table 83. WestRock Recent Development Table 84. Colbert Packaging Company Information Table 85. Colbert Packaging Business Overview Table 86. Colbert Packaging Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Colbert Packaging Child-resistant Pharmaceutical Packaging Product Portfolio Table 88. Colbert Packaging Recent Development Table 89. Kaufman Container Company Information Table 90. Kaufman Container Business Overview Table 91. Kaufman Container Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Kaufman Container Child-resistant Pharmaceutical Packaging Product Portfolio Table 93. Kaufman Container Recent Development Table 94. LeafLocker Company Information Table 95. LeafLocker Business Overview Table 96. LeafLocker Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. LeafLocker Child-resistant Pharmaceutical Packaging Product Portfolio Table 98. LeafLocker Recent Development Table 99. Mold-Rite Plastics Company Information Table 100. Mold-Rite Plastics Business Overview Table 101. Mold-Rite Plastics Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Mold-Rite Plastics Child-resistant Pharmaceutical Packaging Product Portfolio Table 103. Mold-Rite Plastics Recent Development Table 104. Körber Pharma Company Information Table 105. Körber Pharma Business Overview Table 106. Körber Pharma Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Körber Pharma Child-resistant Pharmaceutical Packaging Product Portfolio Table 108. Körber Pharma Recent Development Table 109. Gerresheimer Company Information Table 110. Gerresheimer Business Overview Table 111. Gerresheimer Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Gerresheimer Child-resistant Pharmaceutical Packaging Product Portfolio Table 113. Gerresheimer Recent Development Table 114. Drug Plastics Company Information Table 115. Drug Plastics Business Overview Table 116. Drug Plastics Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Drug Plastics Child-resistant Pharmaceutical Packaging Product Portfolio Table 118. Drug Plastics Recent Development Table 119. Locked4Kids Company Information Table 120. Locked4Kids Business Overview Table 121. Locked4Kids Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Locked4Kids Child-resistant Pharmaceutical Packaging Product Portfolio Table 123. Locked4Kids Recent Development Table 124. Aluberg Company Information Table 125. Aluberg Business Overview Table 126. Aluberg Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Aluberg Child-resistant Pharmaceutical Packaging Product Portfolio Table 128. Aluberg Recent Development Table 129. IGBressan Company Information Table 130. IGBressan Business Overview Table 131. IGBressan Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. IGBressan Child-resistant Pharmaceutical Packaging Product Portfolio Table 133. IGBressan Recent Development Table 134. BOBST Company Information Table 135. BOBST Business Overview Table 136. BOBST Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. BOBST Child-resistant Pharmaceutical Packaging Product Portfolio Table 138. BOBST Recent Development Table 139. SGD Pharma Company Information Table 140. SGD Pharma Business Overview Table 141. SGD Pharma Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. SGD Pharma Child-resistant Pharmaceutical Packaging Product Portfolio Table 143. SGD Pharma Recent Development Table 144. Dymapak Company Information Table 145. Dymapak Business Overview Table 146. Dymapak Child-resistant Pharmaceutical Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Dymapak Child-resistant Pharmaceutical Packaging Product Portfolio Table 148. Dymapak Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Child-resistant Pharmaceutical Packaging Distributors List Table 152. Child-resistant Pharmaceutical Packaging Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Child-resistant Pharmaceutical Packaging Product Image Figure 2. Global Child-resistant Pharmaceutical Packaging Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Child-resistant Pharmaceutical Packaging Sales Value (2021-2032) & (US$ Million) Figure 4. Global Child-resistant Pharmaceutical Packaging Sales (2021-2032) & (k units) Figure 5. Global Child-resistant Pharmaceutical Packaging Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Child-resistant Pharmaceutical Packaging Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Peel Off Type Image Figure 10. Press Type Image Figure 11. Others Image Figure 12. Global Child-resistant Pharmaceutical Packaging Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Child-resistant Pharmaceutical Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Child-resistant Pharmaceutical Packaging Sales Volume Share by Type (2021-2032) Figure 15. Global Child-resistant Pharmaceutical Packaging Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Child-resistant Pharmaceutical Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Child-resistant Pharmaceutical Packaging Sales Value Share by Type (2021-2032) Figure 18. Household Image Figure 19. Commercial Image Figure 20. Global Child-resistant Pharmaceutical Packaging Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Child-resistant Pharmaceutical Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Child-resistant Pharmaceutical Packaging Sales Volume Share by Application (2021-2032) Figure 23. Global Child-resistant Pharmaceutical Packaging Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Child-resistant Pharmaceutical Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Child-resistant Pharmaceutical Packaging Sales Value Share by Application (2021-2032) Figure 26. Global Child-resistant Pharmaceutical Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Child-resistant Pharmaceutical Packaging Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Child-resistant Pharmaceutical Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Child-resistant Pharmaceutical Packaging Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Child-resistant Pharmaceutical Packaging Sales Value (2021-2032) & (US$ Million) Figure 31. North America Child-resistant Pharmaceutical Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Child-resistant Pharmaceutical Packaging Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Child-resistant Pharmaceutical Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Child-resistant Pharmaceutical Packaging Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Child-resistant Pharmaceutical Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Child-resistant Pharmaceutical Packaging Sales Value (2021-2032) & (US$ Million) Figure 37. South America Child-resistant Pharmaceutical Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Child-resistant Pharmaceutical Packaging Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Child-resistant Pharmaceutical Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Child-resistant Pharmaceutical Packaging Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Child-resistant Pharmaceutical Packaging Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Peel Off Type
  • Press Type
  • Others
Applications
  • Household
  • Commercial
Companies covered
  • Amcor
  • Sanner GmbH
  • Origin Pharma Packaging
  • WestRock
  • Colbert Packaging
  • Kaufman Container
  • LeafLocker
  • Mold-Rite Plastics
  • Körber Pharma
  • Gerresheimer
  • Drug Plastics
  • Locked4Kids
  • Aluberg
  • IGBressan
  • BOBST
  • SGD Pharma
  • Dymapak

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Child-resistant Pharmaceutical Packaging Sales Value (2021-2032)
  4. 1.2.2 Global Child-resistant Pharmaceutical Packaging Sales Volume (2021-2032)
  5. 1.2.3 Global Child-resistant Pharmaceutical Packaging Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Child-resistant Pharmaceutical Packaging Market Dynamics
  1. 2.1 Child-resistant Pharmaceutical Packaging Industry Trends
  2. 2.2 Child-resistant Pharmaceutical Packaging Industry Drivers
  3. 2.3 Child-resistant Pharmaceutical Packaging Industry Opportunities and Challenges
  4. 2.4 Child-resistant Pharmaceutical Packaging Industry Restraints
3 Child-resistant Pharmaceutical Packaging Market by Company
  1. 3.1 Global Child-resistant Pharmaceutical Packaging Company Revenue Ranking in 2025
  2. 3.2 Global Child-resistant Pharmaceutical Packaging Revenue by Company (2021-2026)
  3. 3.3 Global Child-resistant Pharmaceutical Packaging Sales Volume by Company (2021-2026)
  4. 3.4 Global Child-resistant Pharmaceutical Packaging Average Price by Company (2021-2026)
  5. 3.5 Global Child-resistant Pharmaceutical Packaging Company Ranking (2024-2026)
  6. 3.6 Global Child-resistant Pharmaceutical Packaging Company Manufacturing Base and Headquarters
  7. 3.7 Global Child-resistant Pharmaceutical Packaging Company Product Type and Application
  8. 3.8 Global Child-resistant Pharmaceutical Packaging Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Child-resistant Pharmaceutical Packaging Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Child-resistant Pharmaceutical Packaging Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Child-resistant Pharmaceutical Packaging Market by Type
  1. 4.1 Child-resistant Pharmaceutical Packaging Type Introduction
  2. 4.1.1 Peel Off Type
  3. 4.1.2 Press Type
  4. 4.1.3 Others
  5. 4.2 Global Child-resistant Pharmaceutical Packaging Sales Volume by Type
  6. 4.2.1 Global Child-resistant Pharmaceutical Packaging Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Child-resistant Pharmaceutical Packaging Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Child-resistant Pharmaceutical Packaging Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Child-resistant Pharmaceutical Packaging Sales Value by Type
  10. 4.3.1 Global Child-resistant Pharmaceutical Packaging Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Child-resistant Pharmaceutical Packaging Sales Value by Type (2021-2032)
  12. 4.3.3 Global Child-resistant Pharmaceutical Packaging Sales Value Share by Type (2021-2032)
5 Child-resistant Pharmaceutical Packaging Market by Application
  1. 5.1 Child-resistant Pharmaceutical Packaging Application Introduction
  2. 5.1.1 Household
  3. 5.1.2 Commercial
  4. 5.2 Global Child-resistant Pharmaceutical Packaging Sales Volume by Application
  5. 5.2.1 Global Child-resistant Pharmaceutical Packaging Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Child-resistant Pharmaceutical Packaging Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Child-resistant Pharmaceutical Packaging Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Child-resistant Pharmaceutical Packaging Sales Value by Application
  9. 5.3.1 Global Child-resistant Pharmaceutical Packaging Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Child-resistant Pharmaceutical Packaging Sales Value by Application (2021-2032)
  11. 5.3.3 Global Child-resistant Pharmaceutical Packaging Sales Value Share by Application (2021-2032)
6 Child-resistant Pharmaceutical Packaging Regional Sales and Value Analysis
  1. 6.1 Global Child-resistant Pharmaceutical Packaging Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Child-resistant Pharmaceutical Packaging Sales by Region (2021-2032)
  3. 6.2.1 Global Child-resistant Pharmaceutical Packaging Sales by Region: 2021-2026
  4. 6.2.2 Global Child-resistant Pharmaceutical Packaging Sales by Region (2027-2032)
  5. 6.3 Global Child-resistant Pharmaceutical Packaging Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Child-resistant Pharmaceutical Packaging Sales Value by Region (2021-2032)
  7. 6.4.1 Global Child-resistant Pharmaceutical Packaging Sales Value by Region: 2021-2026
  8. 6.4.2 Global Child-resistant Pharmaceutical Packaging Sales Value by Region (2027-2032)
  9. 6.5 Global Child-resistant Pharmaceutical Packaging Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Child-resistant Pharmaceutical Packaging Sales Value (2021-2032)
  12. 6.6.2 North America Child-resistant Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Child-resistant Pharmaceutical Packaging Sales Value (2021-2032)
  15. 6.7.2 Europe Child-resistant Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Child-resistant Pharmaceutical Packaging Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Child-resistant Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Child-resistant Pharmaceutical Packaging Sales Value (2021-2032)
  21. 6.9.2 South America Child-resistant Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Child-resistant Pharmaceutical Packaging Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Child-resistant Pharmaceutical Packaging Sales Value Share by Country, 2025 VS 2032
7 Child-resistant Pharmaceutical Packaging Country-level Sales and Value Analysis
  1. 7.1 Global Child-resistant Pharmaceutical Packaging Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Child-resistant Pharmaceutical Packaging Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Child-resistant Pharmaceutical Packaging Sales by Country (2021-2032)
  4. 7.3.1 Global Child-resistant Pharmaceutical Packaging Sales by Country (2021-2026)
  5. 7.3.2 Global Child-resistant Pharmaceutical Packaging Sales by Country (2027-2032)
  6. 7.4 Global Child-resistant Pharmaceutical Packaging Sales Value by Country (2021-2032)
  7. 7.4.1 Global Child-resistant Pharmaceutical Packaging Sales Value by Country (2021-2026)
  8. 7.4.2 Global Child-resistant Pharmaceutical Packaging Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Child-resistant Pharmaceutical Packaging Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Child-resistant Pharmaceutical Packaging Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Child-resistant Pharmaceutical Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amcor
  2. 8.1.1 Amcor Company Information
  3. 8.1.2 Amcor Business Overview
  4. 8.1.3 Amcor Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Amcor Child-resistant Pharmaceutical Packaging Product Portfolio
  6. 8.1.5 Amcor Recent Developments
  7. 8.2 Sanner GmbH
  8. 8.2.1 Sanner GmbH Company Information
  9. 8.2.2 Sanner GmbH Business Overview
  10. 8.2.3 Sanner GmbH Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanner GmbH Child-resistant Pharmaceutical Packaging Product Portfolio
  12. 8.2.5 Sanner GmbH Recent Developments
  13. 8.3 Origin Pharma Packaging
  14. 8.3.1 Origin Pharma Packaging Company Information
  15. 8.3.2 Origin Pharma Packaging Business Overview
  16. 8.3.3 Origin Pharma Packaging Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Origin Pharma Packaging Child-resistant Pharmaceutical Packaging Product Portfolio
  18. 8.3.5 Origin Pharma Packaging Recent Developments
  19. 8.4 WestRock
  20. 8.4.1 WestRock Company Information
  21. 8.4.2 WestRock Business Overview
  22. 8.4.3 WestRock Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 WestRock Child-resistant Pharmaceutical Packaging Product Portfolio
  24. 8.4.5 WestRock Recent Developments
  25. 8.5 Colbert Packaging
  26. 8.5.1 Colbert Packaging Company Information
  27. 8.5.2 Colbert Packaging Business Overview
  28. 8.5.3 Colbert Packaging Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Colbert Packaging Child-resistant Pharmaceutical Packaging Product Portfolio
  30. 8.5.5 Colbert Packaging Recent Developments
  31. 8.6 Kaufman Container
  32. 8.6.1 Kaufman Container Company Information
  33. 8.6.2 Kaufman Container Business Overview
  34. 8.6.3 Kaufman Container Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kaufman Container Child-resistant Pharmaceutical Packaging Product Portfolio
  36. 8.6.5 Kaufman Container Recent Developments
  37. 8.7 LeafLocker
  38. 8.7.1 LeafLocker Company Information
  39. 8.7.2 LeafLocker Business Overview
  40. 8.7.3 LeafLocker Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LeafLocker Child-resistant Pharmaceutical Packaging Product Portfolio
  42. 8.7.5 LeafLocker Recent Developments
  43. 8.8 Mold-Rite Plastics
  44. 8.8.1 Mold-Rite Plastics Company Information
  45. 8.8.2 Mold-Rite Plastics Business Overview
  46. 8.8.3 Mold-Rite Plastics Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Mold-Rite Plastics Child-resistant Pharmaceutical Packaging Product Portfolio
  48. 8.8.5 Mold-Rite Plastics Recent Developments
  49. 8.9 Körber Pharma
  50. 8.9.1 Körber Pharma Company Information
  51. 8.9.2 Körber Pharma Business Overview
  52. 8.9.3 Körber Pharma Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Körber Pharma Child-resistant Pharmaceutical Packaging Product Portfolio
  54. 8.9.5 Körber Pharma Recent Developments
  55. 8.10 Gerresheimer
  56. 8.10.1 Gerresheimer Company Information
  57. 8.10.2 Gerresheimer Business Overview
  58. 8.10.3 Gerresheimer Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Gerresheimer Child-resistant Pharmaceutical Packaging Product Portfolio
  60. 8.10.5 Gerresheimer Recent Developments
  61. 8.11 Drug Plastics
  62. 8.11.1 Drug Plastics Company Information
  63. 8.11.2 Drug Plastics Business Overview
  64. 8.11.3 Drug Plastics Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Drug Plastics Child-resistant Pharmaceutical Packaging Product Portfolio
  66. 8.11.5 Drug Plastics Recent Developments
  67. 8.12 Locked4Kids
  68. 8.12.1 Locked4Kids Company Information
  69. 8.12.2 Locked4Kids Business Overview
  70. 8.12.3 Locked4Kids Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Locked4Kids Child-resistant Pharmaceutical Packaging Product Portfolio
  72. 8.12.5 Locked4Kids Recent Developments
  73. 8.13 Aluberg
  74. 8.13.1 Aluberg Company Information
  75. 8.13.2 Aluberg Business Overview
  76. 8.13.3 Aluberg Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Aluberg Child-resistant Pharmaceutical Packaging Product Portfolio
  78. 8.13.5 Aluberg Recent Developments
  79. 8.14 IGBressan
  80. 8.14.1 IGBressan Company Information
  81. 8.14.2 IGBressan Business Overview
  82. 8.14.3 IGBressan Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 IGBressan Child-resistant Pharmaceutical Packaging Product Portfolio
  84. 8.14.5 IGBressan Recent Developments
  85. 8.15 BOBST
  86. 8.15.1 BOBST Company Information
  87. 8.15.2 BOBST Business Overview
  88. 8.15.3 BOBST Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 BOBST Child-resistant Pharmaceutical Packaging Product Portfolio
  90. 8.15.5 BOBST Recent Developments
  91. 8.16 SGD Pharma
  92. 8.16.1 SGD Pharma Company Information
  93. 8.16.2 SGD Pharma Business Overview
  94. 8.16.3 SGD Pharma Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 SGD Pharma Child-resistant Pharmaceutical Packaging Product Portfolio
  96. 8.16.5 SGD Pharma Recent Developments
  97. 8.17 Dymapak
  98. 8.17.1 Dymapak Company Information
  99. 8.17.2 Dymapak Business Overview
  100. 8.17.3 Dymapak Child-resistant Pharmaceutical Packaging Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Dymapak Child-resistant Pharmaceutical Packaging Product Portfolio
  102. 8.17.5 Dymapak Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Child-resistant Pharmaceutical Packaging Value Chain Analysis
  2. 9.1.1 Child-resistant Pharmaceutical Packaging Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Child-resistant Pharmaceutical Packaging Sales Mode & Process
  6. 9.2 Child-resistant Pharmaceutical Packaging Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Child-resistant Pharmaceutical Packaging Distributors
  9. 9.2.3 Child-resistant Pharmaceutical Packaging Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst